ARQL Market Cap History
Below is a table of the ARQL market cap history going back to 2/16/2010:

Date ARQL Market Cap
2/16/2010146.70M
4/28/2010290.67M
7/27/2010200.19M
11/1/2010235.09M
2/16/2011332.94M
4/27/2011371.51M
7/27/2011306.25M
10/26/2011308.66M
2/16/2012426.73M
3/23/2012389.14M
4/26/2012448.47M
7/24/2012365.58M
10/24/2012157.10M
2/25/2013148.36M
4/29/2013192.26M
7/22/2013162.45M
10/28/2013146.10M
2/25/2014144.59M
4/23/2014105.38M
7/23/201490.39M
10/27/201471.56M
2/24/201584.79M
4/22/2015132.55M
7/22/2015114.44M
10/22/2015135.22M
2/17/2016108.24M
4/20/2016129.33M
7/20/2016115.90M
10/24/2016103.12M
2/24/201789.63M
4/20/201771.86M
7/20/201791.10M
10/25/201789.72M
2/20/2018143.73M
4/20/2018250.05M
7/19/2018566.94M
10/17/2018495.92M
2/20/2019360.80M
4/17/2019693.02M
7/24/20191.26B
10/16/20191.08B

Also see: ARQL Shares Outstanding History
and ARQL YTD Return
ARQL Historical Market Cap:
+22.98% CAGR
ARQL Historical Market Cap: +22.98% CAGR

Mouse over chart for data details
2/16/2010 ...10/16/2019
ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. Co.'s clinical pipeline includes: ARQ 531, which is a reversible dual inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; Miransertib, which is a selective inhibitor of protein kinase B (AKT) in combination with the hormonal therapy, anastrozole; ARQ 751, which is a selective inhibitor of AKT for solid tumors harboring AKT, phosphoinositide 3-kinase or phosphatase and tensin homolog (PTEN) mutations or that are PTEN null; and Derazantinib, which is a multi-kinase inhibitor. We show 41 historical shares outstanding datapoints in our ARQL shares outstanding history coverage, used to compute ARQL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARQL market cap history over the course of time is important for investors interested in comparing ARQL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARQL versus a peer is one thing; comparing ARQL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARQL can fluctuate over the course of history. With this page we aim to empower investors researching ARQL by allowing them to research the ARQL market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARQL:
ARQL SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ArQule (ARQL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARRY Market Cap History
ARWR Market Cap History
ASMB Market Cap History
ASNS Market Cap History
ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
ATOS Market Cap History
ATRA Market Cap History
ATRC Market Cap History
More Healthcare companies »

 

ARQL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.